Global Antimicrobial Growth Promoters Market

Antimicrobial Growth Promoters Comprehensive Study by Type (Antibiotic Growth Promoters, Non-Antibiotic Growth Promoters), Application (Animal Feed, Therapeutic Antimicrobial Drugs, Other), Sales Channels (Distributors, Direct Sales), Non-Antibiotics (Prebiotics & Probiotics, Acidifiers, Phytogenics, Feed Enzymes, Hormones, Others), Animals (Poultry, Swine, Livestock, Aquaculture, Others) Players and Region - Global Market Outlook to 2028

Antimicrobial Growth Promoters Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Antimicrobial growth promoters are antibiotics supplementary to the feed of animal food that enhance their growth rate and productivity. AGPs helps in reducing normal intestinal flora and harmful gut bacteria. This industry is witnessing huge growth because of an increase in the combination of both fewer normal intestinal flora and fewer harmful bacteria.This growth is primarily driven by Rapid Development in the Global Meat Industry .

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Volume UnitK Units
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Chemicals sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Vendors, such as Cargill (United States), Royal DSM (Netherlands), Zoetis (United States), Alltech (United States), Elanco Animal Health (United States), Merck and Co. Inc. (United States), Vetoquinol (France), Bupo Animal Health (South Africa), CHR Hansen (United States) and Novus International Inc. (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In February 2022, Zoetis acquired Jurox. Zoetis and Jurox develop, manufacture, and sell animal health products that detect, prevent, or treat health issues in companion and production animals. This acquisition helped company to expand its presence in Antimicrobial Growth Promoters market
In April 1, 2021, Cargill and including Ausvet, Heifer International, and the International Poultry Council (IPC) partnered for livestock management and combat the threat of zoonotic diseases to both human and animal health by the United States Agency for International Development . This partnership helped company to expand its presence in antimicrobial growth promoters marketsThe market is fragmented by key market players, and those are focusing on advanced production technologies, improving efficiency, and product life. With the increase in market growth opportunities that is captured by tracking the ongoing process improvement and financial flexibility to invest in business growth strategies.

Influencing Trend:
Increase in Research and Development and High Rivalry in the Industry

Market Growth Drivers:
Rapid Development in the Global Meat Industry, Increase In Alternatives to Antibiotics and Hormones and Growing Demand for Non-Antibiotic Growth Promoters and Development in Animal Epidemics and Climate Changes

Challenges:
High Cost Associated With the Global Feed Tonnage

Restraints:
Stringent Regulations That Prohibit the Usage of Antibiotics and Hormones for Growth Promotion in Animals

Opportunities:
Focus on Increasing Environment Sustainability and The Rise in Pressure by the Usage of Glycopeptides as Growth Promoters

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Vendors landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Antimicrobial Growth Promoters Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Antimicrobial Growth Promoters Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Antimicrobial Growth Promoters players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Antimicrobial Growth Promoters Study Sheds Light on
— The Antimicrobial Growth Promoters Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Antimicrobial Growth Promoters industry Vendors. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Antimicrobial Growth Promoters industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Vendors can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Antibiotic Growth Promoters
  • Non-Antibiotic Growth Promoters
By Application
  • Animal Feed
  • Therapeutic Antimicrobial Drugs
  • Other
By Sales Channels
  • Distributors
  • Direct Sales

By Non-Antibiotics
  • Prebiotics & Probiotics
  • Acidifiers
  • Phytogenics
  • Feed Enzymes
  • Hormones
  • Others

By Animals
  • Poultry
  • Swine
  • Livestock
  • Aquaculture
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rapid Development in the Global Meat Industry
      • 3.2.2. Increase In Alternatives to Antibiotics and Hormones and Growing Demand for Non-Antibiotic Growth Promoters
      • 3.2.3. Development in Animal Epidemics and Climate Changes
    • 3.3. Market Challenges
      • 3.3.1. High Cost Associated With the Global Feed Tonnage
    • 3.4. Market Trends
      • 3.4.1. Increase in Research and Development
      • 3.4.2. High Rivalry in the Industry
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Antimicrobial Growth Promoters, by Type, Application, Sales Channels, Non-Antibiotics, Animals and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Antimicrobial Growth Promoters (Value)
      • 5.2.1. Global Antimicrobial Growth Promoters by: Type (Value)
        • 5.2.1.1. Antibiotic Growth Promoters
        • 5.2.1.2. Non-Antibiotic Growth Promoters
      • 5.2.2. Global Antimicrobial Growth Promoters by: Application (Value)
        • 5.2.2.1. Animal Feed
        • 5.2.2.2. Therapeutic Antimicrobial Drugs
        • 5.2.2.3. Other
      • 5.2.3. Global Antimicrobial Growth Promoters by: Sales Channels (Value)
        • 5.2.3.1. Distributors
        • 5.2.3.2. Direct Sales
      • 5.2.4. Global Antimicrobial Growth Promoters by: Non-Antibiotics (Value)
        • 5.2.4.1. Prebiotics & Probiotics
        • 5.2.4.2. Acidifiers
        • 5.2.4.3. Phytogenics
        • 5.2.4.4. Feed Enzymes
        • 5.2.4.5. Hormones
        • 5.2.4.6. Others
      • 5.2.5. Global Antimicrobial Growth Promoters by: Animals (Value)
        • 5.2.5.1. Poultry
        • 5.2.5.2. Swine
        • 5.2.5.3. Livestock
        • 5.2.5.4. Aquaculture
        • 5.2.5.5. Others
      • 5.2.6. Global Antimicrobial Growth Promoters Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Antimicrobial Growth Promoters (Volume)
      • 5.3.1. Global Antimicrobial Growth Promoters by: Type (Volume)
        • 5.3.1.1. Antibiotic Growth Promoters
        • 5.3.1.2. Non-Antibiotic Growth Promoters
      • 5.3.2. Global Antimicrobial Growth Promoters by: Application (Volume)
        • 5.3.2.1. Animal Feed
        • 5.3.2.2. Therapeutic Antimicrobial Drugs
        • 5.3.2.3. Other
      • 5.3.3. Global Antimicrobial Growth Promoters by: Sales Channels (Volume)
        • 5.3.3.1. Distributors
        • 5.3.3.2. Direct Sales
      • 5.3.4. Global Antimicrobial Growth Promoters by: Non-Antibiotics (Volume)
        • 5.3.4.1. Prebiotics & Probiotics
        • 5.3.4.2. Acidifiers
        • 5.3.4.3. Phytogenics
        • 5.3.4.4. Feed Enzymes
        • 5.3.4.5. Hormones
        • 5.3.4.6. Others
      • 5.3.5. Global Antimicrobial Growth Promoters by: Animals (Volume)
        • 5.3.5.1. Poultry
        • 5.3.5.2. Swine
        • 5.3.5.3. Livestock
        • 5.3.5.4. Aquaculture
        • 5.3.5.5. Others
      • 5.3.6. Global Antimicrobial Growth Promoters Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Antimicrobial Growth Promoters (Price)
      • 5.4.1. Global Antimicrobial Growth Promoters by: Type (Price)
  • 6. Antimicrobial Growth Promoters: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cargill (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Royal DSM (Netherlands)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Zoetis (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Alltech (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Elanco Animal Health (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merck and Co. Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Vetoquinol (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bupo Animal Health (South Africa)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. CHR Hansen (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Novus International Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Antimicrobial Growth Promoters Sale, by Type, Application, Sales Channels, Non-Antibiotics, Animals and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Antimicrobial Growth Promoters (Value)
      • 7.2.1. Global Antimicrobial Growth Promoters by: Type (Value)
        • 7.2.1.1. Antibiotic Growth Promoters
        • 7.2.1.2. Non-Antibiotic Growth Promoters
      • 7.2.2. Global Antimicrobial Growth Promoters by: Application (Value)
        • 7.2.2.1. Animal Feed
        • 7.2.2.2. Therapeutic Antimicrobial Drugs
        • 7.2.2.3. Other
      • 7.2.3. Global Antimicrobial Growth Promoters by: Sales Channels (Value)
        • 7.2.3.1. Distributors
        • 7.2.3.2. Direct Sales
      • 7.2.4. Global Antimicrobial Growth Promoters by: Non-Antibiotics (Value)
        • 7.2.4.1. Prebiotics & Probiotics
        • 7.2.4.2. Acidifiers
        • 7.2.4.3. Phytogenics
        • 7.2.4.4. Feed Enzymes
        • 7.2.4.5. Hormones
        • 7.2.4.6. Others
      • 7.2.5. Global Antimicrobial Growth Promoters by: Animals (Value)
        • 7.2.5.1. Poultry
        • 7.2.5.2. Swine
        • 7.2.5.3. Livestock
        • 7.2.5.4. Aquaculture
        • 7.2.5.5. Others
      • 7.2.6. Global Antimicrobial Growth Promoters Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Antimicrobial Growth Promoters (Volume)
      • 7.3.1. Global Antimicrobial Growth Promoters by: Type (Volume)
        • 7.3.1.1. Antibiotic Growth Promoters
        • 7.3.1.2. Non-Antibiotic Growth Promoters
      • 7.3.2. Global Antimicrobial Growth Promoters by: Application (Volume)
        • 7.3.2.1. Animal Feed
        • 7.3.2.2. Therapeutic Antimicrobial Drugs
        • 7.3.2.3. Other
      • 7.3.3. Global Antimicrobial Growth Promoters by: Sales Channels (Volume)
        • 7.3.3.1. Distributors
        • 7.3.3.2. Direct Sales
      • 7.3.4. Global Antimicrobial Growth Promoters by: Non-Antibiotics (Volume)
        • 7.3.4.1. Prebiotics & Probiotics
        • 7.3.4.2. Acidifiers
        • 7.3.4.3. Phytogenics
        • 7.3.4.4. Feed Enzymes
        • 7.3.4.5. Hormones
        • 7.3.4.6. Others
      • 7.3.5. Global Antimicrobial Growth Promoters by: Animals (Volume)
        • 7.3.5.1. Poultry
        • 7.3.5.2. Swine
        • 7.3.5.3. Livestock
        • 7.3.5.4. Aquaculture
        • 7.3.5.5. Others
      • 7.3.6. Global Antimicrobial Growth Promoters Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Antimicrobial Growth Promoters (Price)
      • 7.4.1. Global Antimicrobial Growth Promoters by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Antimicrobial Growth Promoters: by Type(USD Million)
  • Table 2. Antimicrobial Growth Promoters Antibiotic Growth Promoters , by Region USD Million (2017-2022)
  • Table 3. Antimicrobial Growth Promoters Non-Antibiotic Growth Promoters , by Region USD Million (2017-2022)
  • Table 4. Antimicrobial Growth Promoters: by Application(USD Million)
  • Table 5. Antimicrobial Growth Promoters Animal Feed , by Region USD Million (2017-2022)
  • Table 6. Antimicrobial Growth Promoters Therapeutic Antimicrobial Drugs , by Region USD Million (2017-2022)
  • Table 7. Antimicrobial Growth Promoters Other , by Region USD Million (2017-2022)
  • Table 8. Antimicrobial Growth Promoters: by Sales Channels(USD Million)
  • Table 9. Antimicrobial Growth Promoters Distributors , by Region USD Million (2017-2022)
  • Table 10. Antimicrobial Growth Promoters Direct Sales , by Region USD Million (2017-2022)
  • Table 11. Antimicrobial Growth Promoters: by Non-Antibiotics(USD Million)
  • Table 12. Antimicrobial Growth Promoters Prebiotics & Probiotics , by Region USD Million (2017-2022)
  • Table 13. Antimicrobial Growth Promoters Acidifiers , by Region USD Million (2017-2022)
  • Table 14. Antimicrobial Growth Promoters Phytogenics , by Region USD Million (2017-2022)
  • Table 15. Antimicrobial Growth Promoters Feed Enzymes , by Region USD Million (2017-2022)
  • Table 16. Antimicrobial Growth Promoters Hormones , by Region USD Million (2017-2022)
  • Table 17. Antimicrobial Growth Promoters Others , by Region USD Million (2017-2022)
  • Table 18. Antimicrobial Growth Promoters: by Animals(USD Million)
  • Table 19. Antimicrobial Growth Promoters Poultry , by Region USD Million (2017-2022)
  • Table 20. Antimicrobial Growth Promoters Swine , by Region USD Million (2017-2022)
  • Table 21. Antimicrobial Growth Promoters Livestock , by Region USD Million (2017-2022)
  • Table 22. Antimicrobial Growth Promoters Aquaculture , by Region USD Million (2017-2022)
  • Table 23. Antimicrobial Growth Promoters Others , by Region USD Million (2017-2022)
  • Table 24. South America Antimicrobial Growth Promoters, by Country USD Million (2017-2022)
  • Table 25. South America Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 26. South America Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 27. South America Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 28. South America Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 29. South America Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 30. Brazil Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 31. Brazil Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 32. Brazil Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 33. Brazil Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 34. Brazil Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 35. Argentina Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 36. Argentina Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 37. Argentina Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 38. Argentina Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 39. Argentina Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 40. Rest of South America Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 41. Rest of South America Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 42. Rest of South America Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 43. Rest of South America Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 44. Rest of South America Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 45. Asia Pacific Antimicrobial Growth Promoters, by Country USD Million (2017-2022)
  • Table 46. Asia Pacific Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 47. Asia Pacific Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 48. Asia Pacific Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 49. Asia Pacific Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 50. Asia Pacific Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 51. China Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 52. China Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 53. China Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 54. China Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 55. China Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 56. Japan Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 57. Japan Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 58. Japan Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 59. Japan Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 60. Japan Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 61. India Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 62. India Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 63. India Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 64. India Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 65. India Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 66. South Korea Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 67. South Korea Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 68. South Korea Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 69. South Korea Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 70. South Korea Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 71. Taiwan Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 72. Taiwan Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 73. Taiwan Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 74. Taiwan Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 75. Taiwan Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 76. Australia Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 77. Australia Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 78. Australia Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 79. Australia Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 80. Australia Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 81. Rest of Asia-Pacific Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 82. Rest of Asia-Pacific Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 83. Rest of Asia-Pacific Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 84. Rest of Asia-Pacific Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 85. Rest of Asia-Pacific Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 86. Europe Antimicrobial Growth Promoters, by Country USD Million (2017-2022)
  • Table 87. Europe Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 88. Europe Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 89. Europe Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 90. Europe Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 91. Europe Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 92. Germany Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 93. Germany Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 94. Germany Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 95. Germany Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 96. Germany Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 97. France Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 98. France Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 99. France Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 100. France Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 101. France Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 102. Italy Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 103. Italy Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 104. Italy Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 105. Italy Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 106. Italy Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 107. United Kingdom Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 108. United Kingdom Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 109. United Kingdom Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 110. United Kingdom Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 111. United Kingdom Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 112. Netherlands Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 113. Netherlands Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 114. Netherlands Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 115. Netherlands Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 116. Netherlands Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 117. Rest of Europe Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 118. Rest of Europe Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 119. Rest of Europe Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 120. Rest of Europe Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 121. Rest of Europe Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 122. MEA Antimicrobial Growth Promoters, by Country USD Million (2017-2022)
  • Table 123. MEA Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 124. MEA Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 125. MEA Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 126. MEA Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 127. MEA Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 128. Middle East Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 129. Middle East Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 130. Middle East Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 131. Middle East Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 132. Middle East Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 133. Africa Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 134. Africa Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 135. Africa Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 136. Africa Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 137. Africa Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 138. North America Antimicrobial Growth Promoters, by Country USD Million (2017-2022)
  • Table 139. North America Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 140. North America Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 141. North America Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 142. North America Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 143. North America Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 144. United States Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 145. United States Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 146. United States Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 147. United States Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 148. United States Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 149. Canada Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 150. Canada Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 151. Canada Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 152. Canada Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 153. Canada Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 154. Mexico Antimicrobial Growth Promoters, by Type USD Million (2017-2022)
  • Table 155. Mexico Antimicrobial Growth Promoters, by Application USD Million (2017-2022)
  • Table 156. Mexico Antimicrobial Growth Promoters, by Sales Channels USD Million (2017-2022)
  • Table 157. Mexico Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2017-2022)
  • Table 158. Mexico Antimicrobial Growth Promoters, by Animals USD Million (2017-2022)
  • Table 159. Antimicrobial Growth Promoters Sales: by Type(K Units)
  • Table 160. Antimicrobial Growth Promoters Sales Antibiotic Growth Promoters , by Region K Units (2017-2022)
  • Table 161. Antimicrobial Growth Promoters Sales Non-Antibiotic Growth Promoters , by Region K Units (2017-2022)
  • Table 162. Antimicrobial Growth Promoters Sales: by Application(K Units)
  • Table 163. Antimicrobial Growth Promoters Sales Animal Feed , by Region K Units (2017-2022)
  • Table 164. Antimicrobial Growth Promoters Sales Therapeutic Antimicrobial Drugs , by Region K Units (2017-2022)
  • Table 165. Antimicrobial Growth Promoters Sales Other , by Region K Units (2017-2022)
  • Table 166. Antimicrobial Growth Promoters Sales: by Sales Channels(K Units)
  • Table 167. Antimicrobial Growth Promoters Sales Distributors , by Region K Units (2017-2022)
  • Table 168. Antimicrobial Growth Promoters Sales Direct Sales , by Region K Units (2017-2022)
  • Table 169. Antimicrobial Growth Promoters Sales: by Non-Antibiotics(K Units)
  • Table 170. Antimicrobial Growth Promoters Sales Prebiotics & Probiotics , by Region K Units (2017-2022)
  • Table 171. Antimicrobial Growth Promoters Sales Acidifiers , by Region K Units (2017-2022)
  • Table 172. Antimicrobial Growth Promoters Sales Phytogenics , by Region K Units (2017-2022)
  • Table 173. Antimicrobial Growth Promoters Sales Feed Enzymes , by Region K Units (2017-2022)
  • Table 174. Antimicrobial Growth Promoters Sales Hormones , by Region K Units (2017-2022)
  • Table 175. Antimicrobial Growth Promoters Sales Others , by Region K Units (2017-2022)
  • Table 176. Antimicrobial Growth Promoters Sales: by Animals(K Units)
  • Table 177. Antimicrobial Growth Promoters Sales Poultry , by Region K Units (2017-2022)
  • Table 178. Antimicrobial Growth Promoters Sales Swine , by Region K Units (2017-2022)
  • Table 179. Antimicrobial Growth Promoters Sales Livestock , by Region K Units (2017-2022)
  • Table 180. Antimicrobial Growth Promoters Sales Aquaculture , by Region K Units (2017-2022)
  • Table 181. Antimicrobial Growth Promoters Sales Others , by Region K Units (2017-2022)
  • Table 182. South America Antimicrobial Growth Promoters Sales, by Country K Units (2017-2022)
  • Table 183. South America Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 184. South America Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 185. South America Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 186. South America Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 187. South America Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 188. Brazil Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 189. Brazil Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 190. Brazil Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 191. Brazil Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 192. Brazil Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 193. Argentina Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 194. Argentina Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 195. Argentina Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 196. Argentina Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 197. Argentina Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 198. Rest of South America Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 199. Rest of South America Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 200. Rest of South America Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 201. Rest of South America Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 202. Rest of South America Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 203. Asia Pacific Antimicrobial Growth Promoters Sales, by Country K Units (2017-2022)
  • Table 204. Asia Pacific Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 205. Asia Pacific Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 206. Asia Pacific Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 207. Asia Pacific Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 208. Asia Pacific Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 209. China Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 210. China Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 211. China Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 212. China Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 213. China Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 214. Japan Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 215. Japan Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 216. Japan Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 217. Japan Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 218. Japan Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 219. India Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 220. India Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 221. India Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 222. India Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 223. India Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 224. South Korea Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 225. South Korea Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 226. South Korea Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 227. South Korea Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 228. South Korea Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 229. Taiwan Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 230. Taiwan Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 231. Taiwan Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 232. Taiwan Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 233. Taiwan Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 234. Australia Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 235. Australia Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 236. Australia Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 237. Australia Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 238. Australia Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 239. Rest of Asia-Pacific Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 240. Rest of Asia-Pacific Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 241. Rest of Asia-Pacific Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 242. Rest of Asia-Pacific Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 243. Rest of Asia-Pacific Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 244. Europe Antimicrobial Growth Promoters Sales, by Country K Units (2017-2022)
  • Table 245. Europe Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 246. Europe Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 247. Europe Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 248. Europe Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 249. Europe Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 250. Germany Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 251. Germany Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 252. Germany Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 253. Germany Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 254. Germany Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 255. France Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 256. France Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 257. France Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 258. France Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 259. France Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 260. Italy Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 261. Italy Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 262. Italy Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 263. Italy Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 264. Italy Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 265. United Kingdom Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 266. United Kingdom Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 267. United Kingdom Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 268. United Kingdom Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 269. United Kingdom Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 270. Netherlands Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 271. Netherlands Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 272. Netherlands Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 273. Netherlands Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 274. Netherlands Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 275. Rest of Europe Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 276. Rest of Europe Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 277. Rest of Europe Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 278. Rest of Europe Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 279. Rest of Europe Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 280. MEA Antimicrobial Growth Promoters Sales, by Country K Units (2017-2022)
  • Table 281. MEA Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 282. MEA Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 283. MEA Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 284. MEA Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 285. MEA Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 286. Middle East Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 287. Middle East Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 288. Middle East Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 289. Middle East Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 290. Middle East Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 291. Africa Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 292. Africa Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 293. Africa Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 294. Africa Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 295. Africa Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 296. North America Antimicrobial Growth Promoters Sales, by Country K Units (2017-2022)
  • Table 297. North America Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 298. North America Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 299. North America Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 300. North America Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 301. North America Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 302. United States Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 303. United States Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 304. United States Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 305. United States Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 306. United States Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 307. Canada Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 308. Canada Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 309. Canada Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 310. Canada Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 311. Canada Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 312. Mexico Antimicrobial Growth Promoters Sales, by Type K Units (2017-2022)
  • Table 313. Mexico Antimicrobial Growth Promoters Sales, by Application K Units (2017-2022)
  • Table 314. Mexico Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2017-2022)
  • Table 315. Mexico Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2017-2022)
  • Table 316. Mexico Antimicrobial Growth Promoters Sales, by Animals K Units (2017-2022)
  • Table 317. Antimicrobial Growth Promoters: by Type(USD/Units)
  • Table 318. Company Basic Information, Sales Area and Its Competitors
  • Table 319. Company Basic Information, Sales Area and Its Competitors
  • Table 320. Company Basic Information, Sales Area and Its Competitors
  • Table 321. Company Basic Information, Sales Area and Its Competitors
  • Table 322. Company Basic Information, Sales Area and Its Competitors
  • Table 323. Company Basic Information, Sales Area and Its Competitors
  • Table 324. Company Basic Information, Sales Area and Its Competitors
  • Table 325. Company Basic Information, Sales Area and Its Competitors
  • Table 326. Company Basic Information, Sales Area and Its Competitors
  • Table 327. Company Basic Information, Sales Area and Its Competitors
  • Table 328. Antimicrobial Growth Promoters: by Type(USD Million)
  • Table 329. Antimicrobial Growth Promoters Antibiotic Growth Promoters , by Region USD Million (2023-2028)
  • Table 330. Antimicrobial Growth Promoters Non-Antibiotic Growth Promoters , by Region USD Million (2023-2028)
  • Table 331. Antimicrobial Growth Promoters: by Application(USD Million)
  • Table 332. Antimicrobial Growth Promoters Animal Feed , by Region USD Million (2023-2028)
  • Table 333. Antimicrobial Growth Promoters Therapeutic Antimicrobial Drugs , by Region USD Million (2023-2028)
  • Table 334. Antimicrobial Growth Promoters Other , by Region USD Million (2023-2028)
  • Table 335. Antimicrobial Growth Promoters: by Sales Channels(USD Million)
  • Table 336. Antimicrobial Growth Promoters Distributors , by Region USD Million (2023-2028)
  • Table 337. Antimicrobial Growth Promoters Direct Sales , by Region USD Million (2023-2028)
  • Table 338. Antimicrobial Growth Promoters: by Non-Antibiotics(USD Million)
  • Table 339. Antimicrobial Growth Promoters Prebiotics & Probiotics , by Region USD Million (2023-2028)
  • Table 340. Antimicrobial Growth Promoters Acidifiers , by Region USD Million (2023-2028)
  • Table 341. Antimicrobial Growth Promoters Phytogenics , by Region USD Million (2023-2028)
  • Table 342. Antimicrobial Growth Promoters Feed Enzymes , by Region USD Million (2023-2028)
  • Table 343. Antimicrobial Growth Promoters Hormones , by Region USD Million (2023-2028)
  • Table 344. Antimicrobial Growth Promoters Others , by Region USD Million (2023-2028)
  • Table 345. Antimicrobial Growth Promoters: by Animals(USD Million)
  • Table 346. Antimicrobial Growth Promoters Poultry , by Region USD Million (2023-2028)
  • Table 347. Antimicrobial Growth Promoters Swine , by Region USD Million (2023-2028)
  • Table 348. Antimicrobial Growth Promoters Livestock , by Region USD Million (2023-2028)
  • Table 349. Antimicrobial Growth Promoters Aquaculture , by Region USD Million (2023-2028)
  • Table 350. Antimicrobial Growth Promoters Others , by Region USD Million (2023-2028)
  • Table 351. South America Antimicrobial Growth Promoters, by Country USD Million (2023-2028)
  • Table 352. South America Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 353. South America Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 354. South America Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 355. South America Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 356. South America Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 357. Brazil Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 358. Brazil Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 359. Brazil Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 360. Brazil Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 361. Brazil Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 362. Argentina Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 363. Argentina Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 364. Argentina Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 365. Argentina Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 366. Argentina Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 367. Rest of South America Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 368. Rest of South America Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 369. Rest of South America Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 370. Rest of South America Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 371. Rest of South America Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 372. Asia Pacific Antimicrobial Growth Promoters, by Country USD Million (2023-2028)
  • Table 373. Asia Pacific Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 374. Asia Pacific Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 375. Asia Pacific Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 376. Asia Pacific Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 377. Asia Pacific Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 378. China Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 379. China Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 380. China Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 381. China Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 382. China Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 383. Japan Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 384. Japan Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 385. Japan Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 386. Japan Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 387. Japan Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 388. India Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 389. India Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 390. India Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 391. India Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 392. India Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 393. South Korea Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 394. South Korea Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 395. South Korea Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 396. South Korea Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 397. South Korea Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 398. Taiwan Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 399. Taiwan Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 400. Taiwan Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 401. Taiwan Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 402. Taiwan Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 403. Australia Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 404. Australia Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 405. Australia Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 406. Australia Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 407. Australia Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 408. Rest of Asia-Pacific Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 409. Rest of Asia-Pacific Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 410. Rest of Asia-Pacific Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 411. Rest of Asia-Pacific Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 412. Rest of Asia-Pacific Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 413. Europe Antimicrobial Growth Promoters, by Country USD Million (2023-2028)
  • Table 414. Europe Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 415. Europe Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 416. Europe Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 417. Europe Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 418. Europe Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 419. Germany Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 420. Germany Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 421. Germany Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 422. Germany Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 423. Germany Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 424. France Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 425. France Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 426. France Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 427. France Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 428. France Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 429. Italy Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 430. Italy Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 431. Italy Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 432. Italy Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 433. Italy Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 434. United Kingdom Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 435. United Kingdom Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 436. United Kingdom Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 437. United Kingdom Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 438. United Kingdom Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 439. Netherlands Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 440. Netherlands Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 441. Netherlands Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 442. Netherlands Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 443. Netherlands Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 444. Rest of Europe Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 445. Rest of Europe Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 446. Rest of Europe Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 447. Rest of Europe Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 448. Rest of Europe Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 449. MEA Antimicrobial Growth Promoters, by Country USD Million (2023-2028)
  • Table 450. MEA Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 451. MEA Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 452. MEA Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 453. MEA Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 454. MEA Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 455. Middle East Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 456. Middle East Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 457. Middle East Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 458. Middle East Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 459. Middle East Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 460. Africa Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 461. Africa Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 462. Africa Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 463. Africa Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 464. Africa Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 465. North America Antimicrobial Growth Promoters, by Country USD Million (2023-2028)
  • Table 466. North America Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 467. North America Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 468. North America Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 469. North America Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 470. North America Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 471. United States Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 472. United States Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 473. United States Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 474. United States Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 475. United States Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 476. Canada Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 477. Canada Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 478. Canada Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 479. Canada Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 480. Canada Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 481. Mexico Antimicrobial Growth Promoters, by Type USD Million (2023-2028)
  • Table 482. Mexico Antimicrobial Growth Promoters, by Application USD Million (2023-2028)
  • Table 483. Mexico Antimicrobial Growth Promoters, by Sales Channels USD Million (2023-2028)
  • Table 484. Mexico Antimicrobial Growth Promoters, by Non-Antibiotics USD Million (2023-2028)
  • Table 485. Mexico Antimicrobial Growth Promoters, by Animals USD Million (2023-2028)
  • Table 486. Antimicrobial Growth Promoters Sales: by Type(K Units)
  • Table 487. Antimicrobial Growth Promoters Sales Antibiotic Growth Promoters , by Region K Units (2023-2028)
  • Table 488. Antimicrobial Growth Promoters Sales Non-Antibiotic Growth Promoters , by Region K Units (2023-2028)
  • Table 489. Antimicrobial Growth Promoters Sales: by Application(K Units)
  • Table 490. Antimicrobial Growth Promoters Sales Animal Feed , by Region K Units (2023-2028)
  • Table 491. Antimicrobial Growth Promoters Sales Therapeutic Antimicrobial Drugs , by Region K Units (2023-2028)
  • Table 492. Antimicrobial Growth Promoters Sales Other , by Region K Units (2023-2028)
  • Table 493. Antimicrobial Growth Promoters Sales: by Sales Channels(K Units)
  • Table 494. Antimicrobial Growth Promoters Sales Distributors , by Region K Units (2023-2028)
  • Table 495. Antimicrobial Growth Promoters Sales Direct Sales , by Region K Units (2023-2028)
  • Table 496. Antimicrobial Growth Promoters Sales: by Non-Antibiotics(K Units)
  • Table 497. Antimicrobial Growth Promoters Sales Prebiotics & Probiotics , by Region K Units (2023-2028)
  • Table 498. Antimicrobial Growth Promoters Sales Acidifiers , by Region K Units (2023-2028)
  • Table 499. Antimicrobial Growth Promoters Sales Phytogenics , by Region K Units (2023-2028)
  • Table 500. Antimicrobial Growth Promoters Sales Feed Enzymes , by Region K Units (2023-2028)
  • Table 501. Antimicrobial Growth Promoters Sales Hormones , by Region K Units (2023-2028)
  • Table 502. Antimicrobial Growth Promoters Sales Others , by Region K Units (2023-2028)
  • Table 503. Antimicrobial Growth Promoters Sales: by Animals(K Units)
  • Table 504. Antimicrobial Growth Promoters Sales Poultry , by Region K Units (2023-2028)
  • Table 505. Antimicrobial Growth Promoters Sales Swine , by Region K Units (2023-2028)
  • Table 506. Antimicrobial Growth Promoters Sales Livestock , by Region K Units (2023-2028)
  • Table 507. Antimicrobial Growth Promoters Sales Aquaculture , by Region K Units (2023-2028)
  • Table 508. Antimicrobial Growth Promoters Sales Others , by Region K Units (2023-2028)
  • Table 509. South America Antimicrobial Growth Promoters Sales, by Country K Units (2023-2028)
  • Table 510. South America Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 511. South America Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 512. South America Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 513. South America Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 514. South America Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 515. Brazil Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 516. Brazil Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 517. Brazil Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 518. Brazil Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 519. Brazil Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 520. Argentina Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 521. Argentina Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 522. Argentina Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 523. Argentina Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 524. Argentina Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 525. Rest of South America Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 526. Rest of South America Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 527. Rest of South America Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 528. Rest of South America Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 529. Rest of South America Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 530. Asia Pacific Antimicrobial Growth Promoters Sales, by Country K Units (2023-2028)
  • Table 531. Asia Pacific Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 532. Asia Pacific Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 533. Asia Pacific Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 534. Asia Pacific Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 535. Asia Pacific Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 536. China Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 537. China Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 538. China Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 539. China Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 540. China Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 541. Japan Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 542. Japan Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 543. Japan Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 544. Japan Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 545. Japan Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 546. India Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 547. India Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 548. India Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 549. India Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 550. India Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 551. South Korea Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 552. South Korea Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 553. South Korea Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 554. South Korea Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 555. South Korea Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 556. Taiwan Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 557. Taiwan Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 558. Taiwan Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 559. Taiwan Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 560. Taiwan Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 561. Australia Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 562. Australia Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 563. Australia Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 564. Australia Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 565. Australia Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 566. Rest of Asia-Pacific Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 567. Rest of Asia-Pacific Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 568. Rest of Asia-Pacific Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 569. Rest of Asia-Pacific Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 570. Rest of Asia-Pacific Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 571. Europe Antimicrobial Growth Promoters Sales, by Country K Units (2023-2028)
  • Table 572. Europe Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 573. Europe Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 574. Europe Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 575. Europe Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 576. Europe Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 577. Germany Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 578. Germany Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 579. Germany Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 580. Germany Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 581. Germany Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 582. France Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 583. France Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 584. France Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 585. France Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 586. France Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 587. Italy Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 588. Italy Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 589. Italy Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 590. Italy Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 591. Italy Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 592. United Kingdom Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 593. United Kingdom Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 594. United Kingdom Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 595. United Kingdom Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 596. United Kingdom Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 597. Netherlands Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 598. Netherlands Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 599. Netherlands Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 600. Netherlands Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 601. Netherlands Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 602. Rest of Europe Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 603. Rest of Europe Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 604. Rest of Europe Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 605. Rest of Europe Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 606. Rest of Europe Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 607. MEA Antimicrobial Growth Promoters Sales, by Country K Units (2023-2028)
  • Table 608. MEA Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 609. MEA Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 610. MEA Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 611. MEA Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 612. MEA Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 613. Middle East Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 614. Middle East Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 615. Middle East Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 616. Middle East Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 617. Middle East Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 618. Africa Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 619. Africa Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 620. Africa Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 621. Africa Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 622. Africa Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 623. North America Antimicrobial Growth Promoters Sales, by Country K Units (2023-2028)
  • Table 624. North America Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 625. North America Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 626. North America Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 627. North America Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 628. North America Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 629. United States Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 630. United States Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 631. United States Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 632. United States Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 633. United States Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 634. Canada Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 635. Canada Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 636. Canada Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 637. Canada Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 638. Canada Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 639. Mexico Antimicrobial Growth Promoters Sales, by Type K Units (2023-2028)
  • Table 640. Mexico Antimicrobial Growth Promoters Sales, by Application K Units (2023-2028)
  • Table 641. Mexico Antimicrobial Growth Promoters Sales, by Sales Channels K Units (2023-2028)
  • Table 642. Mexico Antimicrobial Growth Promoters Sales, by Non-Antibiotics K Units (2023-2028)
  • Table 643. Mexico Antimicrobial Growth Promoters Sales, by Animals K Units (2023-2028)
  • Table 644. Antimicrobial Growth Promoters: by Type(USD/Units)
  • Table 645. Research Programs/Design for This Report
  • Table 646. Key Data Information from Secondary Sources
  • Table 647. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Antimicrobial Growth Promoters: by Type USD Million (2017-2022)
  • Figure 5. Global Antimicrobial Growth Promoters: by Application USD Million (2017-2022)
  • Figure 6. Global Antimicrobial Growth Promoters: by Sales Channels USD Million (2017-2022)
  • Figure 7. Global Antimicrobial Growth Promoters: by Non-Antibiotics USD Million (2017-2022)
  • Figure 8. Global Antimicrobial Growth Promoters: by Animals USD Million (2017-2022)
  • Figure 9. South America Antimicrobial Growth Promoters Share (%), by Country
  • Figure 10. Asia Pacific Antimicrobial Growth Promoters Share (%), by Country
  • Figure 11. Europe Antimicrobial Growth Promoters Share (%), by Country
  • Figure 12. MEA Antimicrobial Growth Promoters Share (%), by Country
  • Figure 13. North America Antimicrobial Growth Promoters Share (%), by Country
  • Figure 14. Global Antimicrobial Growth Promoters: by Type K Units (2017-2022)
  • Figure 15. Global Antimicrobial Growth Promoters: by Application K Units (2017-2022)
  • Figure 16. Global Antimicrobial Growth Promoters: by Sales Channels K Units (2017-2022)
  • Figure 17. Global Antimicrobial Growth Promoters: by Non-Antibiotics K Units (2017-2022)
  • Figure 18. Global Antimicrobial Growth Promoters: by Animals K Units (2017-2022)
  • Figure 19. South America Antimicrobial Growth Promoters Share (%), by Country
  • Figure 20. Asia Pacific Antimicrobial Growth Promoters Share (%), by Country
  • Figure 21. Europe Antimicrobial Growth Promoters Share (%), by Country
  • Figure 22. MEA Antimicrobial Growth Promoters Share (%), by Country
  • Figure 23. North America Antimicrobial Growth Promoters Share (%), by Country
  • Figure 24. Global Antimicrobial Growth Promoters: by Type USD/Units (2017-2022)
  • Figure 25. Global Antimicrobial Growth Promoters share by Players 2022 (%)
  • Figure 26. Global Antimicrobial Growth Promoters share by Players (Top 3) 2022(%)
  • Figure 27. Global Antimicrobial Growth Promoters share by Players (Top 5) 2022(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. Cargill (United States) Revenue, Net Income and Gross profit
  • Figure 30. Cargill (United States) Revenue: by Geography 2022
  • Figure 31. Royal DSM (Netherlands) Revenue, Net Income and Gross profit
  • Figure 32. Royal DSM (Netherlands) Revenue: by Geography 2022
  • Figure 33. Zoetis (United States) Revenue, Net Income and Gross profit
  • Figure 34. Zoetis (United States) Revenue: by Geography 2022
  • Figure 35. Alltech (United States) Revenue, Net Income and Gross profit
  • Figure 36. Alltech (United States) Revenue: by Geography 2022
  • Figure 37. Elanco Animal Health (United States) Revenue, Net Income and Gross profit
  • Figure 38. Elanco Animal Health (United States) Revenue: by Geography 2022
  • Figure 39. Merck and Co. Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Merck and Co. Inc. (United States) Revenue: by Geography 2022
  • Figure 41. Vetoquinol (France) Revenue, Net Income and Gross profit
  • Figure 42. Vetoquinol (France) Revenue: by Geography 2022
  • Figure 43. Bupo Animal Health (South Africa) Revenue, Net Income and Gross profit
  • Figure 44. Bupo Animal Health (South Africa) Revenue: by Geography 2022
  • Figure 45. CHR Hansen (United States) Revenue, Net Income and Gross profit
  • Figure 46. CHR Hansen (United States) Revenue: by Geography 2022
  • Figure 47. Novus International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 48. Novus International Inc. (United States) Revenue: by Geography 2022
  • Figure 49. Global Antimicrobial Growth Promoters: by Type USD Million (2023-2028)
  • Figure 50. Global Antimicrobial Growth Promoters: by Application USD Million (2023-2028)
  • Figure 51. Global Antimicrobial Growth Promoters: by Sales Channels USD Million (2023-2028)
  • Figure 52. Global Antimicrobial Growth Promoters: by Non-Antibiotics USD Million (2023-2028)
  • Figure 53. Global Antimicrobial Growth Promoters: by Animals USD Million (2023-2028)
  • Figure 54. South America Antimicrobial Growth Promoters Share (%), by Country
  • Figure 55. Asia Pacific Antimicrobial Growth Promoters Share (%), by Country
  • Figure 56. Europe Antimicrobial Growth Promoters Share (%), by Country
  • Figure 57. MEA Antimicrobial Growth Promoters Share (%), by Country
  • Figure 58. North America Antimicrobial Growth Promoters Share (%), by Country
  • Figure 59. Global Antimicrobial Growth Promoters: by Type K Units (2023-2028)
  • Figure 60. Global Antimicrobial Growth Promoters: by Application K Units (2023-2028)
  • Figure 61. Global Antimicrobial Growth Promoters: by Sales Channels K Units (2023-2028)
  • Figure 62. Global Antimicrobial Growth Promoters: by Non-Antibiotics K Units (2023-2028)
  • Figure 63. Global Antimicrobial Growth Promoters: by Animals K Units (2023-2028)
  • Figure 64. South America Antimicrobial Growth Promoters Share (%), by Country
  • Figure 65. Asia Pacific Antimicrobial Growth Promoters Share (%), by Country
  • Figure 66. Europe Antimicrobial Growth Promoters Share (%), by Country
  • Figure 67. MEA Antimicrobial Growth Promoters Share (%), by Country
  • Figure 68. North America Antimicrobial Growth Promoters Share (%), by Country
  • Figure 69. Global Antimicrobial Growth Promoters: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Cargill (United States)
  • Royal DSM (Netherlands)
  • Zoetis (United States)
  • Alltech (United States)
  • Elanco Animal Health (United States)
  • Merck and Co. Inc. (United States)
  • Vetoquinol (France)
  • Bupo Animal Health (South Africa)
  • CHR Hansen (United States)
  • Novus International Inc. (United States)
Additional players considered in the study are as follows:
Associated British Foods (ABF) plc (United Kingdom) , ERBER AG (United Kingdom) , Archer-Daniels-Midland Company (United States)
Select User Access Type

Key Highlights of Report


May 2023 217 Pages 89 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Antimicrobial Growth Promoters Market Quantitative research analysis
Global Antimicrobial Growth Promoters Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2023 to 2028
Companies that are profiled in Global Antimicrobial Growth Promoters Market are Cargill (United States), Royal DSM (Netherlands), Zoetis (United States), Alltech (United States), Elanco Animal Health (United States), Merck and Co. Inc. (United States), Vetoquinol (France), Bupo Animal Health (South Africa), CHR Hansen (United States) and Novus International Inc. (United States) etc.
Animal Feed segment in Global market to hold robust market share owing to "Rapid Development in the Global Meat Industry ".
AMA Research predicts that United States Vendors will contribute to the maximum growth of Global Antimicrobial Growth Promoters market throughout the forecasted period.

Know More About Global Antimicrobial Growth Promoters Market Report?

Have a Query? Click Here

Other Related Reports

Agricultural Pheromones Comprehensive Study by Type (Releaser Pheromones, Primers Pheromones), Application (Detection & Monitoring, Mass Trapping, Mating Disruption), Crop (Citrus Fruit, Seeded Fruit...
$ 3350
Syngas Chemicals Comprehensive Study by Type (Methanol, Acetyls, Formaldehyde & Resins, Methyl Tertiary-Butyl Ether(MTBE)), Application (Fertilizers, Fuels, Solvent, Synthetic Materials), Production ...
$ 3800
Organic Paper Dyes Comprehensive Study by Type (Powder, Liquid), Application (Packaging and Board, Coated Paper, Writing and Printing, Tissues, Others) Players and Region - Global Market Outlook to 2...
$ 3500
Fish-free Omega-3 Ingredients Comprehensive Study by Type (Alpha-Linolenic Acid (ALA), Eicosapentaenoic Acid (EPA), Docosahexaenoic Acid (DHA)), Application (Food Industry, Beverage Industry, Dietary...
$ 3750
Offshore Oil Pipeline Comprehensive Study by Type (Oil, Gas, Others), Line Typ (Transportation Line, Export Line, Others), Installation Technique (S-Lay, J-Lay, Reel-Lay, Towed system), Diameter (8–1...
$ 3800
Lithium Methoxide Comprehensive Study by Type (Liquid, Powder), Application (Food and Agriculture, Military, Pharmaceutical, Others), Distribution Chanel (Online, Offline) Players and Region - Global...
$ 3500